- Home
- NRO vs SCPH Comparison
NRO vs SCPH Comparison
Compare NRO & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- SCPH
- Stock Information
- Founded
- NRO 2003
- SCPH 2013
- Country
- NRO United States
- SCPH United States
- Employees
- NRO N/A
- SCPH N/A
- Industry
- NRO Finance/Investors Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- SCPH Health Care
- Exchange
- NRO Nasdaq
- SCPH Nasdaq
- Market Cap
- NRO 156.7M
- SCPH 173.6M
- IPO Year
- NRO N/A
- SCPH 2017
- Fundamental
- Price
- NRO $3.27
- SCPH $3.97
- Analyst Decision
- NRO
- SCPH Strong Buy
- Analyst Count
- NRO 0
- SCPH 3
- Target Price
- NRO N/A
- SCPH $14.00
- AVG Volume (30 Days)
- NRO 239.4K
- SCPH 289.9K
- Earning Date
- NRO 01-01-0001
- SCPH 08-13-2025
- Dividend Yield
- NRO 11.41%
- SCPH N/A
- EPS Growth
- NRO N/A
- SCPH N/A
- EPS
- NRO N/A
- SCPH N/A
- Revenue
- NRO N/A
- SCPH $41,982,000.00
- Revenue This Year
- NRO N/A
- SCPH $108.95
- Revenue Next Year
- NRO N/A
- SCPH $73.83
- P/E Ratio
- NRO N/A
- SCPH N/A
- Revenue Growth
- NRO N/A
- SCPH 138.10
- 52 Week Low
- NRO $2.51
- SCPH $1.94
- 52 Week High
- NRO $3.45
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- NRO 55.93
- SCPH 61.96
- Support Level
- NRO $3.19
- SCPH $3.77
- Resistance Level
- NRO $3.27
- SCPH $4.08
- Average True Range (ATR)
- NRO 0.04
- SCPH 0.17
- MACD
- NRO 0.00
- SCPH -0.04
- Stochastic Oscillator
- NRO 86.08
- SCPH 76.92
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.